DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Messersmith WA, Laheru DA, Senzer NN. et al.
Phase I trial of irinotecan, infusional 5-fluorouracil, and leucovorin (FOLFIRI) with erlotinib (OSI-774): early termination due to increased toxicities.
Clin Cancer Res 2004; 10: 6522-6527
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.